Bertold R Fridlender

Title: Bertold R. Fridlender: Innovator in Immunoassay Technology

Introduction

Bertold R. Fridlender is an esteemed inventor based in Jerusalem, Israel, known for his contributions to immunoassay technologies. With a total of two patents to his name, his work has significantly advanced methods for detecting viral antibodies, which are essential in diagnosing various diseases.

Latest Patents

Fridlender's latest inventions include a method called the Combined Heterogeneous Specific Binding Assay. This innovative approach allows for the simultaneous determination of multiple ligands within a single liquid test sample, such as antibodies or antigens. The method employs solid-phase binding agents for different ligands that are differentially separable, enabling the use of a single label rather than multiple labels for each ligand. This technique is particularly beneficial for simultaneously detecting various antibodies, especially those targeting different viral antigens in a single serum sample.

Another noteworthy invention by Fridlender is his Immunoassay Method for Detecting Viral Antibodies in Whole Blood Samples. This method involves incubating diluted whole human blood with a solid-phase form of a viral antigen, allowing any antibodies present to bind to it. After separating the resulting complexes, a labeled antibody is used to measure the amount of binding, indicating the presence of the original antibodies. This technique is particularly effective for detecting antibodies related to cytomegalovirus and Rubella.

Career Highlights

Bertold R. Fridlender is associated with Ames-Yissum Ltd., where he has applied his expertise in developing diagnostic technologies. His patents reflect a deep understanding of immunology and biochemistry, contributing to advancements in medical diagnostics.

Collaborations

During his career, Fridlender has collaborated with talented coworkers such as Zohar Ben-Moyal and Udi Olshevsky. Together, they have furthered the development of innovative solutions in their field, working towards better medical diagnostics and patient care.

Conclusion

Bertold R. Fridlender exemplifies the spirit of innovation in the medical field, particularly in the area of immunoassays. His patented methods promise to enhance diagnostic capabilities, ensuring more accurate and efficient detection of viral antibodies. As he continues to work alongside dedicated professionals, Fridlender's contributions will undoubtedly lead to further advancements in health technology.